How many insider declarations has Glenmark Pharmaceuticals Limited filed?

Glenmark Pharmaceuticals Limited has filed 2 public insider declarations with SEBI (PIT + SAST).

What is Glenmark Pharmaceuticals Limited's role?

Glenmark Pharmaceuticals Limited's reported role is not specified by the regulator across the filings.

Which companies does Glenmark Pharmaceuticals Limited report trades for?

Glenmark Pharmaceuticals Limited reports trades for Alivus Life Sciences Limited.

← Executives ★ Sign in to follow

GP

Glenmark Pharmaceuticals Limited

·SEBI (PIT + SAST)

Alivus Life Sciences Limited

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Glenmark Pharmaceuticals Limited. Director active across 1 company, notably Alivus Life Sciences Limited. Cumulatively, 2 disclosures have been recorded. History available since 21 September 2023. The latest transaction was disclosed on 6 March 2024 (Sale). Regulator: SEBI (PIT + SAST). All data is free.

Companies and markets linked to Glenmark Pharmaceuticals Limited

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Alivus Life Sciences Limited (IN)IN insider transactions · SEBI (PIT + SAST)

Declarations2 total

●

Glenmark Pharmaceuticals Limited

Executives6 Mar 2024Alivus Life Sciences Limited

₹40B10SEBI ↗

67,389,944 shares@ ₹597.993887.0% of flowEquity SharesSEBI:7a6580285e4ab87778892b1e6940df5b0906ece1

●

Glenmark Pharmaceuticals Limited

Executives21 Sept 2023Alivus Life Sciences Limited

₹6B3SEBI ↗

9,609,571 shares@ ₹615.0013.0% of flowEquity SharesSEBI:a028b009998f2b6cd0e9f0078c26b6d97e983bed

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

GP

Glenmark Pharmaceuticals Limited

·SEBI (PIT + SAST)

Alivus Life Sciences Limited

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Glenmark Pharmaceuticals Limited. Director active across 1 company, notably Alivus Life Sciences Limited. Cumulatively, 2 disclosures have been recorded. History available since 21 September 2023. The latest transaction was disclosed on 6 March 2024 (Sale). Regulator: SEBI (PIT + SAST). All data is free.